Treace Medical Concepts (TMCI) EBITDA Margin (2020 - 2026)
Treace Medical Concepts' (TMCI) quarterly EBITDA Margin came in at 36.37% in Q1 2026, down 673.0% YoY from 6.35% in Q1 2025, and down 283.99% on a QoQ basis from 9.47% in Q4 2025.
Treace Medical Concepts (TMCI) EBITDA Margin (2020 - 2026) Analysis & Trends
Treace Medical Concepts (TMCI) has 7 years of EBITDA Margin data on file, last reported at 36.37% in Q1 2026.
- Quarterly EBITDA Margin fell 673.0% year-over-year to 36.37% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 26.89% (down 208.0% YoY) and the FY2025 annual result came in at 25.46%, up 114.0% from the prior year.
- EBITDA Margin eased to 36.37% in Q1 2026, from 9.47% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 0.3% in Q4 2024 to a low of 48.1% in Q2 2024.
- A 5-year average of 28.76% and a median of 32.65% in 2023 frame the typical range for EBITDA Margin.
- Annual changes were most pronounced in 2022 — EBITDA Margin tumbled 2038 bps — and 2025, when it soared 1228 bps.
- Tracing TMCI's EBITDA Margin over 5 years: stood at 7.03% in 2022, then sank by 55 bps to 10.9% in 2023, then soared by 97 bps to 0.3% in 2024, then sank by 3090 bps to 9.47% in 2025, then plunged by 284 bps to 36.37% in 2026.
- The last three EBITDA Margin figures came in at 36.37% (Q1 2026), 9.47% (Q4 2025), and 31.22% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.61 Bn | 194.01 Bn | 7.27 Bn | 13.44% |
| 2 | Stryker | 127.81 Bn | 124.34 Bn | 4.50 Bn | 25.18% |
| 3 | Medtronic | 119.04 Bn | 109.82 Bn | 6.41 Bn | 19.10% |
| 4 | Boston Scientific | 73.68 Bn | 73.14 Bn | 3.85 Bn | 21.65% |
| 5 | Edwards Lifesciences | 51.96 Bn | 47.71 Bn | 1.35 Bn | 29.48% |
| 6 | Dexcom | 34.36 Bn | 32.41 Bn | 830.00 Mn | 24.33% |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn | 13.96% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 10.30% |
| 9 | Steris | 23.06 Bn | 22.58 Bn | 684.20 Mn | 19.15% |
| 10 | Treace Medical Concepts | 281.67 Mn | 236.05 Mn | 35.61 Mn | -32.96% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -32.96% |
| Mar 31, 2026 | -36.37% |
| Dec 31, 2025 | -9.47% |
| Sep 30, 2025 | -31.22% |
| Jun 30, 2025 | -35.82% |
| Mar 31, 2025 | -29.64% |
| Dec 31, 2024 | -0.30% |
| Sep 30, 2024 | -33.57% |
| Jun 30, 2024 | -48.10% |
| Mar 31, 2024 | -37.11% |
| Dec 31, 2023 | -10.90% |
| Sep 30, 2023 | -43.72% |
| Jun 30, 2023 | -31.11% |
| Mar 31, 2023 | -32.65% |
| Dec 31, 2022 | -7.03% |
| Sep 30, 2022 | -34.24% |
| Jun 30, 2022 | -39.82% |
| Mar 31, 2022 | -27.87% |
| Dec 31, 2021 | -16.74% |
| Sep 30, 2021 | -25.26% |